Dinesh V. Ph D. Patel, President and CEO: Protagonist Therapeutics PTGX Sell · Filed 25/07/28

Trade details

Type: Insider sale
Amount: $570,533.7
Shares · price: 10,415 sh · $54.78 a share
Held after: 520,603 sh
Stock: Protagonist Therapeutics PTGX
Person: Dinesh V. Ph D. PatelPresident and CEO
Trade date: 25/07/25
Filed: 25/07/28
Days to filing: 3 days

Sold 2.0% of holdings

Share of holding sold: 2.0%

Protagonist Therapeutics trades, last 26 weeks

What else happened in Protagonist Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/25~25/08/24

Dinesh V. Ph D. Patel's recent trades

Dinesh V. Ph D. PatelPresident and CEO
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$33.6M
225,000 sh
$33.6M
Filed 08/10
Traded 08/10
Dinesh V. Ph D. PatelPresident and CEO
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$7.5M
75,000 sh
$7.5M
Filed 05/14
Traded 05/12
Dinesh V. Ph D. PatelPresident and CEO
SellProtagonist Therapeutics
Sell
Protagonist Therapeutics
PTGX
$7.5M
75,000 sh
$7.5M
Filed 05/12
Traded 05/12
Dinesh V. Ph D. PatelPresident and CEO
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$7.8M
75,000 sh
$7.8M
Filed 05/12
Traded 05/12
Dinesh V. Ph D. PatelPresident and CEO
SellProtagonist Therapeutics
Sell
Protagonist Therapeutics
PTGX
$5.5M
54,641 sh
$5.5M
Filed 03/25
Traded 03/25